Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection

Immunology

Volumn 138, Issue 2, 2013, Pages 145-156

  Borges, Diego C ^a   Araújo, Natalia M ^a   Cardoso, Cristina R ^b   Lazo Chica, Javier E ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Immune response; Inflammation; Parasite inocula; Regulatory T cells; Trypanosoma cruzi

Indexed keywords

CD45RB ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; INOCULATION; MALE; MOUSE; NONHUMAN; PARASITE LOAD; PARASITISM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL RATE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, DIFFERENTIATION; CHAGAS DISEASE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; MALE; MICE; MYOCARDIUM; T-LYMPHOCYTES, REGULATORY; TRYPANOSOMA CRUZI;

EID: 84872663236     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12022     Document Type: Article

References (61)

1. Perez AR, Silva-Barbosa SD, Roggero E et al. Immunoendocrinology of the thymus in Chagas disease. NeuroImmunoModulation 2011; 18:328-38.
2. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 2004; 200:201-10.
3. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-7.
4. Santello FH, Frare EO, dos Santos CD, Caetano LC, Alonso Toldo MP, do Prado JC Jr. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi. J Pineal Res 2008; 45:291-6.
5. Taylor MD, LeGoff L, Harris A, Malone E, Allen JE, Maizels RM. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J Immunol 2005; 174:4924-33.
6. + Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect Immun 2000; 68:197-204.
7. da Matta Guedes PM, Gutierrez FR, Maia FL, Milanezi CM, Silva GK, Pavanelli WR, Silva JS. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 2010; 4:e604.
8. Michailowsky V, Silva NM, Rocha CD, Vieira LQ, Lannes-Vieira J, Gazzinelli RT. Pivotal role of interleukin-12 and interferon-γ axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol 2001; 159:1723-33.
9. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ. Tumor necrosis factor α mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected γ interferon-activated macrophages. Infect Immun 1995; 63:4862-7.
10. + T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 2008; 10:825-33.
11. + cells in chagasic patients with and without megacolon. Hum Immunol 2009; 70:65-7.
12. + T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol 2006; 145:81-92.
13. Higuchi ML, De Morais CF, Pereira Barreto AC, Lopes EA, Stolf N, Bellotti G, Pileggi F. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol 1987; 10:665-70.
14. Yoshida N. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity. Parasitol Int 2008; 57:105-9.
15. Monteiro WM, Barbosa MG, Toledo MJ, Fe FA, Fe NF. [Series of acute Chagas' disease cases attended at a tertiary-level clinic in Manaus, State of Amazonas, from 1980 to 2006]. Rev Soc Bras Med Trop 2010; 43:207-10.
16. Marinho CR, D'Imperio Lima MR, Grisotto MG, Alvarez JM. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun 1999; 67:308-18.
17. Monteon-Padilla V, Hernandez-Becerril N, Ballinas-Verdugo MA, Aranda-Fraustro A, Reyes PA. Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients. Arch Med Res 2001; 32:39-43.
18. Brener Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1962; 4:389-96.
19. Coura JR. Chagas disease: what is known and what is needed - a background article. Mem Inst Oswaldo Cruz 2007; 102(Suppl 1):113-22.
20. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987; 18:619-24.
21. Hally AD. A counting method for measuring the volumes of tissue components in microscopical sections. Q J Microsc Sci 1964; s3-105:503-17.
22. Talvani A, Ribeiro CS, Aliberti JC et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2000; 2:851-66.
23. Silva JS, Twardzik DR, Reed SG. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF-β). J Exp Med 1991; 174:539-45.
24. Camandaroba EL, Campos RF, Magalhaes JB, Andrade SG. Clonal structure of Trypanosoma cruzi Colombian strain (biodeme Type III): biological, isoenzymic and histopathological analysis of seven isolated clones. Rev Soc Bras Med Trop 2001; 34:151-7.
25. Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu YJ, O'Garra A. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003; 197:101-9.
26. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20:29-53.
27. Reis e Sousa C, Yap G, Schulz O, Rogers N, Schito M, Aliberti J, Hieny S, Sher A. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity 1999; 11:637-47.
28. Chaussabel D, Pajak B, Vercruysse V et al. Alteration of migration and maturation of dendritic cells and T-cell depletion in the course of experimental Trypanosoma cruzi infection. Lab Invest 2003; 83:1373-82.
29. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89.
30. Melo RC, Machado CR. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Exp Parasitol 2001; 97:15-23.
31. Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, Gollob KJ, Dutra WO. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun 2004; 72:5283-91.
32. Lopez-Castejon G, Baroja-Mazo A, Pelegrin P. Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules. Cell Mol Life Sci 2011; 68:3095-107.
33. Aliberti JC, Cardoso MA, Martins GA, Gazzinelli RT, Vieira LQ, Silva JS. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 1996; 64:1961-7.
34. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-48.
35. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-52.
36. Kryczek I, Bruce AT, Gudjonsson JE et al. Induction of IL-17 + T cell trafficking and development by IFN-γ: mechanism and pathological relevance in psoriasis. J Immunol 2008; 181:4733-41.
37. Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. Cutting edge: IFN-γ regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006; 177:1416-20.
38. + Th17 cells in a T cell-intrinsic manner. J Immunol 2009; 182:6179-86.
39. Vanden Eijnden S, Goriely S, De Wit D, Goldman M, Willems F. Preferential production of the IL-12(p40)/IL-23(p19) heterodimer by dendritic cells from human newborns. Eur J Immunol 2006; 36:21-6.
40. Basile JI, Geffner LJ, Romero MM et al. Outbreaks of Mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load. J Infect Dis 2011; 204:1054-64.
41. Kenna TJ, Davidson SI, Duan R et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis. Arthritis Rheum 2011; 64:1420-9.
42. + T cells in Trypanosoma cruzi infection. Immunol Rev 2004; 201:304-17.
43. Tarleton RL, Koller BH, Latour A, Postan M. Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992; 356:338-40.
44. + T cells differentiation and proliferation by the timing of increase in the pathogen load. PLoS ONE 2007; 2:e393.
45. + T cells. Infect Immun 2007; 75:231-5.
46. Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992; 175:169-74.
47. + regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun 2007; 75:861-9.
48. + Tr cells. Blood 2005; 105:1162-9.
49. Deaglio S, Dwyer KM, Gao W et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257-65.
50. + T cells. J Immunol 2004; 172:7306-14.
51. Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics 1994; 23:704-6.
52. Ten Hove T, The Olle F, Berkhout M, Bruggeman JP, Vyth-Dreese FA, Slors JF, Van Deventer SJ, Te Velde AA. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. J Leukoc Biol 2004; 75:1010-5.
53. + regulatory T cells. Immunol Rev 2006; 212:60-73.
54. Sztein MB, Kierszenbaum F. Mechanisms of development of immunosuppression during Trypanosoma infections. Parasitol Today 1993; 9:424-8.
55. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002; 195:221-31.
56. Van der Kleij D, Van Remoortere A, Schuitemaker JH, Kapsenberg ML, Deelder AM, Tielens AG, Hokke CH, Yazdanbakhsh M. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc β1-4(Fuc α1-2Fuc α1-3)GlcNAc. J Infect Dis 2002; 185:531-9.
57. Golgher D, Gazzinelli RT. Innate and acquired immunity in the pathogenesis of Chagas disease. Autoimmunity 2004; 37:399-409.
58. Savino W, Villa-Verde DM, Mendes-da-Cruz DA et al. Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi. Cytokine Growth Factor Rev 2007; 18:107-24.
59. Gutierrez FR, Mariano FS, Oliveira CJ et al. Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1. Infect Immun 2011; 79:1873-81.
60. + T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect 2008; 10:680-8.
61. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190:995-1004.